Company overview
Calidi Biotherapeutics develops clinical-stage oncolytic virotherapies and stem cell-based platforms for treating solid tumors and metastatic cancers. Their RedTail platform enables systemic delivery of engineered enveloped viruses like CLD-401, which express IL-15 superagonists to activate anti-tumor immunity. NeuroNova programs, such as CLD-101, use neural stem cells to deliver oncolytic adenoviruses selectively to high-grade gliomas.
Calidi Biotherapeutics is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include oncolytic virotherapy, stem cell immunotherapy, redtail platform, neuronova, solid tumor treatment, metastatic cancer.
Structured facts
- Website
- https://www.calidibio.com
- Markets served
- United States & Americas
- Keywords
- oncolytic virotherapy, stem cell immunotherapy, redtail platform, neuronova, solid tumor treatment, metastatic cancer
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What are Calidi's main therapeutic platforms?
- Calidi's RedTail platform delivers systemic oncolytic viruses for metastatic solid tumors, while NeuroNova uses neural stem cells to carry oncolytic viruses to brain tumors like high-grade gliomas.
- What is the clinical status of their programs?
- CLD-101 is in Phase 1 trials for recurrent high-grade glioma, with first patient dosed. CLD-401 from RedTail is advancing with preclinical data presented at ASCO.
- What tumor types do they target?
- Targets include high-grade gliomas, lung cancer, and over 60 tumor cell lines, focusing on advanced metastatic solid tumors.
Related editorial coverage
- ASGCT 2026: Calidi Bio's RedTail Platform to Present
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
